Aktuality v nefrologie (108)
Elektronická verze časopisu o novinkách v oblastni nefrologie.
Donec porta, nulla eget aliquam aliquet, nibh leo aliquet nulla, nec dapibus est urna eu libero. Sed rutrum odio vel elit auctor sed faucibus metus commodo. Sed dictum dui vitae metus tempor id mollis lorem malesuada. Cras suscipit erat sed diam lobortis non blandit turpis dapibus. Curabitur interdum ante ac eros molestie non semper urna lacinia. Sed sit amet diam ac nibh varius ullamcorper eu ut diam. Morbi ullamcorper feugiat dictum. Suspendisse potenti. Aliquam erat volutpat. Ut et odio id urna tempor eleifend. Maecenas rutrum vestibulum justo.
Mauris vitae tortor nisl. Quisque dignissim tortor eu metus eleifend vitae iaculis nunc tincidunt. Praesent condimentum aliquam tempor. In bibendum sem lorem. Phasellus nec ullamcorper justo. Sed imperdiet semper metus eget auctor. Integer consequat justo eget diam dignissim eu dapibus erat malesuada. Aliquam erat volutpat. Sed ut mauris et risus aliquam aliquam sed et lacus. Mauris bibendum, leo ac bibendum pellentesque, dolor eros pellentesque quam, non blandit libero odio sit amet magna. Nulla ac nibh massa, ac posuere lectus. Aliquam dictum scelerisque volutpat. Proin eu quam et leo eleifend congue dapibus congue lacus.
Podřazené kategorie
Editorial ....................................................................................................... 1
Originální práce
Hemoperfúzia amitriptylínu a nortriptylínu – štúdia in vitro
K. Derzsiová, M. Mydlík, V. Petríková, A. Molčányiová ..................................... 6
IgA v moči pacientů s IgA nefropatií – další pomůcka
v diagnostice této choroby
K. Matoušovic, K. Konečný, J. Novak, M. Tomana, J. Mestecky ...................... 11
Zpráva z kongresu
Renal Week 2004, American Society of Nephrology,
St. Louis, Missouri, USA, 29. 1.–1. 11. 2004
J. Eiselt ..................................................................................................... 18
Zprávy o knihách
NEFROLÓGIA (R. Dzúrik, M. Šašinka, M. Mydlík, L. Kovács)
K. Matoušovic ............................................................................................ 22
Postgraduální vzdělání
Subkatedra nefrologie IPVZ
Akce na první polovinu roku 2005
V. Teplan ................................................................................................... 23
Osobní zprávy
Spomienka na prof. MUDr. Alberta Válka, DrSc. po 10 rokoch
M. Mydlík, K. Derzsiová .............................................................................. 26
Rejstřík ..................................................................................................... 28
Editorial ...................................................................................................... 1
Original papers
Hemoperfusion of amitriptyline and nortriptyline—an in vitro study
K. Derzsiová, M. Mydlík, V. Petríková, A. Molčányiová .................................... 6
Urinary IgA in IgA nephropathy patients - a new finding which
support diagnosis of IgA nephropathy
K. Matoušovic, K. Konečný, J. Novak, M. Tomana, J. Mestecky .................... 11
Congress News
Renal Week 2004, American Society of Nephrology,
St. Louis, Missouri, USA, 29. 1.–1. 11. 2004
J. Eiselt .................................................................................................... 18
Book reviews
NEFROLÓGIA (R. Dzúrik, M. Šašinka, M. Mydlík, L. Kovács)
K. Matoušovic ........................................................................................... 22
Postgraduate education
Division of Nephrology, IPVZ
Events scheduled for the first 6 months of 2005
V. Teplan ................................................................................................. 23
Personal news
A reflection of Prof. Mudr. Alberta Válka, DrSc. After 10 years
M. Mydlík, k. Derzsiová ............................................................................. 26
Index ....................................................................................................... 28
Editorial ........................................................................................ 31
Originální práce
A) 2005 Jan Brod Memorial Meeting
Obrázky z minulosti československé a české nefrologie
J. Jirka ......................................................................................... 39
K histórii slovenskej nefrológie
R. Dzúrik, V. Spustová ................................................................... 41
B) Léčebné postupy u chorob ledvin
Renální odezva na podání antihypertenziv jednotlivých skupin
V. Monhart .................................................................................... 43
Edémové stavy a jejich léčba diuretiky
O. Schück ..................................................................................... 47
Poruchy metabolismu kyseliny močové při nefropatiích.
Role v progresi a léčebná strategie
J. Žabka ........................................................................................ 49
Poruchy metabolismu lipoproteinů při nefropatiích. Role v progresi
a léčebná strategie
V. Tesař ........................................................................................ 52
Léčba nefropatií glukokortikoidy z pohledu nežádoucích účinků
I. Rychlík ....................................................................................... 57
Korekce poruch acidobázické rovnováhy (ABR) u akutních stavů
K. Matoušovic, O. Schück .............................................................. 60
Léčba paraproteinémické nefropatie a primární amyloidózy ledvin
R. Ryšavá ..................................................................................... 62
Diagnostika a liečba porúch kostného metabolizmu
V. Spustová ................................................................................... 65
C) Spolupráce nefrologa s jinými specialisty při diagnostice
a léčbě chorob ledvin
Renální biopsie: dialog klinika a morfologa
P. Rossmann ................................................................................ 68
Pediatrická a internistická nefrológia – čo nás spája a čo nás
rozdeľuje
Ľ. Podracká, M. Šašinka ............................................................... 70
Etiologie, diagnostika a léčba urolitiázy (Aspekty urologické
a nefrologické)
K. Bartoníčková, M. Horáčková ...................................................... 73
Rola diabetológa a nefrológa v diagnostike a liečbe diabetickej choroby
obličiek
P. Ponťuch .................................................................................. 79
Funkce ledvin, metabolismus a účinky léků ve stáří
V. Teplan ..................................................................................... 82
Nefrológ a kardiológ: liečba srdcového zlyhania
A. Okša ....................................................................................... 85
Těhotenství u žen s preexistujícím onemocněním ledvin
I. Rychlík ..................................................................................... 89
Cardiovascular Disease in End Stage Renal Disease (ESRD)
– An Ongoing Challenge for the Nephrologists Now and in the Future
J. E. Hoffmann ............................................................................. 92
Editorial ...................................................................................... 31
Original papers
A) 2005 Jan Brod Memorial Meeting
Remembrance of the history of Czechoslovak and Czech nephrology
J. Jirka ....................................................................................... 39
To the history of Slovak nephrology
R. Dzúrik, V. Spoustová ............................................................... 41
B) Treatment of some renal diseases
Renal response to the antihypertensives of different types
V. Monhart ................................................................................. 43
Oedema and treatment by diuretics
O. Schück .................................................................................. 47
Disturbances of uric acid metabolism in the renal disease.
Their role in a progression, and treatment strategy
J. Žabka ......................................................................................49
Disturbances of lipoproteid metabolism in the renal disease.
Thein role in a progression, and treatment strategy
V. Tesař ..................................................................................... 52
Treatment of nephropathies by glukocorticoids.
Their adverse effects.
I. Rychlík .................................................................................... 57
Correction of acid base balance disturbances in intensive care
unit patiens.
K. Matoušovic, O. Schück ........................................................... 60
Treatment of paraproteinaemic nephropathy
and of primary amyloidosis the kidneys
R. Ryšavá .................................................................................. 62
Diagnosis and treatment of uremic bone disease
V. Spoustová ............................................................................. 65
C) Colaboration between a nephrologist and other
specialist in diagnosis and treatment of the renal disease
Tenal biopsy. A dialog between the morphologist and the clinician.
P. Rossmann ............................................................................ 68
Paediatric and adult nephrology: accordances nad differences
L. Podracká, M. Šašinka ............................................................ 70
Aetiology, diagnosis and treatment of the urinary stones.
K. Bartoníčková, M. Horáčková ................................................... 73
Subscription .............................................................................. 77
Role of a diabetologist and a nephrologist in diagnosis
and treatment of the diabetic nephropathy.
P. Ponťuch ............................................................................... 79
Renal function, renal metabolism and drug administration
in the elderly.
V. Teplan .................................................................................. 82
Nephrologist and cardiologist. Treatment of heart failure
in renal patiens.
A. Okša ................................................................................... 85
Pregnancy in women with the renal disease.
I. Rychlík ................................................................................. 89
Cardiovascular Disease in End Stage Renal Disease (ESRD)
– An Ongoing Challenge for the Nephrologists
Now and in the Future
J. E. Hoffmann ......................................................................... 92
Editorial ........................................................................................... 2
Originální článek
Klinický význam niektorých biochemických
markerov tubulárnej dysfunkcie
u chorých s analgetickou nefropatiou
A. Rajnič ......................................................................................... 7
Zprávy ze světa
Alabamská univerzita v Birminghamu
K. Matoušovic, J. Městecký ............................................................ 15
Kostně-cévní choroba, změna amerického postoje
k cévním přístupùm pro dialýzu
a budoucnost náhrady funkce ledvin.
Postřehy z Renal Week 2005,
American Society of Nephrology,
Filadelfie, Pensylvánie, USA, 7.–13. 11. 2005
J. Eiselt ........................................................................................ 18
Informace o odborných akcích v roce 2006 ....................................... 23
Rejstřík ........................................................................................ 27
Editorial ......................................................................................... 2
Original paper
Clinical relevance of some biochemical markers of tubular
dysfunction in patients with analgesic nephropathy
A. Rajnič ....................................................................................... 7
Rewievs from the world
University of Alabama at Birmingham
K. Matoušovic, J. Městecký .......................................................... 15
Osteovascular disease, a change in the US attitude to vascular
access for dialysis and the future of renal replacement therapy
American Society of Nephrology, Philadelphia, Pennsylvania,
USA, 7.–13. s11. 2005
J. Eiselt ...................................................................................... 18
Information of Scientific Events in 2006 .......................................... 23
Index .......................................................................................... 27
Program kongresu ...............................................................................................................153
Abstrakta ...........................................................................................................................162
Původní práce
Výsledky léčby sekundární hyperparatyreózy u dialyzovaných cinacalcetem:
multicentrické prospektivní sledování MMM – Management Mimpary na Moravě
Jana Smržová, Tomáš Urbánek, Robert Rakowski, Roman Ondraschek,
Patrik Letocha, Milouš Vyskočil, Sylvie Schwarzová, Marie Marsová ........................................ 171
Asymetrický dimethylarginin a pentosidin u nemocných s chronickým onemocněním
ledvin a obezitou: randomizovaná kontrolovaná studie
Vladimír Teplan, Olga Marečková, Ivana Vyhnánková,
Ivo Valkovský, Milan Lopatník, Jaroslav Racek,
Milena Štollová, Dana Sasaková, Jan Malý ............................................................................185
Přehledné práce
Nové pøístupy k testování vlastností peritoneální membrány u pacientů na peritoneální dialýze
Alena Paříková .................................................................................................................... 191
Nové možnosti ovlivnìní kostní a minerálové poruchy dialyzovaných
a jejich potenciální vliv na snížení mortality
Sylvie Opatrná .....................................................................................................................194
Rozhovor .............................................................................................................................198
CONTENTS
Congress timetable ...............................................................................................................153
Abstracts .............................................................................................................................162
Original papers
The results of cinacalcet treatment in dialysis patients with secondary hyperparathyroidism:
multicentre prospective follow-up MMM – the Mimpara Management in Moravia
Jana Smržová, Tomáš Urbánek, Robert Rakowski, Roman Ondraschek,
Patrik Letocha, Milouš Vyskočil, Sylvie Schwarzová, Marie Marsová .......................................... 171
Asymmetric dimethylarginine and pentosidin in patiens with chronic kidney
disease and obesity: a randomized controlled trial
Vladimír Teplan, Olga Marečková, Ivana Vyhnánková, Ivo Valkovský, Milan Lopatník,
Jaroslav Racek, Milena Štollová, Dana Sasaková, Jan Malý ...................................................... 185
Reviews
New approaches in the assessment of peritoneal membrane function
in patients on peritoneal dialysis
Alena Paříková ........................................................................................................................ 191
New options to influence bone and mineral disorderes of dialysis patients
and their potential effect on mortality reduction
Sylvie Opatrná ........................................................................................................................194
Interwiew ................................................................................................................................198
Editorial ...................................................................................................................................113
Přehledné práce
Léčba hemorheoferézou (současný stav a vlastní zkušenosti)
Milan Bláha, Eva Rencová, Radovan Malý, Jakub Dršata, Martin Blažek ....................................... 118
Pomalá hemodialýza (sustained low-efficiency dialysis – SLED)
Roman Štilec, Jan Maňák ...................................................................................................... 125
Původní práce
Léčba anémie u peritoneálně dialyzovaných pacientů – zkušenosti z praxe
Vladko Horčička jr., Karel Krejčí, Pavel Štrébl, Sadeq Al-Jabry, Josef Zadražil .............................. 129
Konverzia z cyklosporínu-A na takrolimus pre vedľajšie účinky cyklosporínu-A
u pacientov po obličkovej transplantácii
Eva Lacková, Juraj Šváč........................................................................................................... 137
Zlepšená kontrola hypertenze vede ke snížení proteinurie a stabilizaci funkce štìpu u pacientů
po transplantaci ledviny
Tomáš Seeman, Karel Vondrák, Jiří Dušek, Jiří Gilík, Pavel Dvořák, Jan Janda .................................142
Rozhovor ..................................................................................................................................150
CONTENTS
Editorial ................................................................................................................................ 113
Reviews
Hemorheotherapy (current status and single centre experience)
Milan Bláha, Eva Rencová, Radovan Malý, Jakub Dršata, Martin Blažek ................................. 118
Slow hemodialysis (sustained low-efficiency dialysis – SLED)
Roman Štilec, Jan Maňák ......................................................................................................125
Original papers
Treatment of anemia in peritoneal dialysis (PD) patients - clinical experience
Vladko Horčička jr., Karel Krejčí, Pavel Štrébl, Sadeq Al-Jabry, Josef Zadražil ............................ 129
Conversion from cyclosporine-A to tacrolimus due to cyclosporine-A
side - effects in renal transplant patients
Eva Lacková, Juraj Šváč ....................................................................................................... 137
Improved control of hypertension leads to decrease
of proteinuria and stabilisation of graft function
in patients after renal transplantation
Tomáš Seeman, Karel Vondrák, Jiří Dušek, Jiří Gilík, Pavel Dvořák, Jan Janda ............................142
Interwiew ........................................................................................................................150
Editorial ............................................................................................. 34
Program kongresu ......................................................................... 43
Abstrakta .......................................................................................... 58
Přehledné práce
Úloha podocytů v patogeneze glomerulopatií
a jejich využití v diagnostice
Peter Habara, Helena Marečková, Vladimír Tesař .................... 93
Hodnocení cévních změn u pacientů s chronickým
selháním ledvin (v tabulkách pro praxi)
Jana Zahálková, Rudolf Metelka,
Naděžda Petejová, Josef Zadražil .............................................. 100
Rozhovor ......................................................................................... 108
Recenze ............................................................................................ 111
CONTENTS
Editorial ............................................................................................. 34
Congress timetable ....................................................................... 43
Abstracts .......................................................................................... 58
Reviews
Podocytes function in pathogenesis
and diagnosis of various glomerulonefritides
Peter Habara, Helena Marečková, Vladimír Tesař .................... 93
Assessment of vascular changes in patients
with chronic kidney failure (in practical tables)
Jana Zahálková, Rudolf Metelka,
Naděžda Petejová, Josef Zadražil ............................................. 100
Interwiew ....................................................................................... 108
Book review .................................................................................... 111
Editorial .................................................................................................... 105
Obsah ...................................................................................................... 109
Doporučení
KDIGO doporučení pro diagnostiku a léčbu CKD-MBD:
komentovaný návod pro klinickou praxi
Sylvie Dusilová Sulková, Sylvie Opatrná, Romana Ryšavá,
Vladimír Tesaø, Vladimír Teplan, Ondøej Viklický,
Jana Zahálková (pracovní skupina) ............................................................... 113
Abstrakta
Medzinárodné nefrologické sympózium ....................................................... 129
Kazuistika
Využití vyšetøení mikrocirkulace pøístrojem LDLS
pro indikaci alprostadilu v léèbì nehojícího se
bércového defektu u transplantovaného pacienta
Erik Mistrík, Sylvie Dusilová-Sulková, Vladimír Bláha,
Jakub Víšek, Luboš Sobotka .................................................................... 145
Rozhovor ................................................................................................ 149
Pøedplatné ............................................................................................. 151
Pokyny autorùm ......................................................................................152
Editorial ................................................................................................. 105
Contents .............................................................................,.................. 109
Recommendations
KDIGO recommendations focused on diagnosis
and treatment of CKD-MBD: commented
approach to clinical practice
Sylvie Dusilová Sulková, Sylvie Opatrná, Romana Ryšavá,
Vladimír Tesaø, Vladimír Teplan, Ondøej Viklický,
Jana Zahálková (working group) ................................................................ 113
Abstracts
International symposium of nephrology ...................................................... 129
Case report
Use of skin microcirculation examination in evaluation
of the effectiveness of alprostadil in the therapy of
non-healing skin ulcus cruris in kidney transplant recipient
Erik Mistrík, Sylvie Dusilová-Sulková, Vladimír Bláha,
Jakub Víšek, Luboš Sobotka .................................................................... 145
Interview ................................................................................................. 149
Subscription ........................................................................................... 151
Instruction to authors ............................................................................... 152
Více...
Editorial ..............................................................89
Obsah ..................................................................91
Abstrakta
33. kongres Slovenskej nefrologickej spoločnosti
s medzinárodnou účasťou ................................................95
Yellow pages
Pùvodní práce
Bicarbonátová hemodialýza s A-koncentrátem s kyselinou
citrónovou (Citrasate®)
František Lopot, František Švára, Vladimír Polakovič ................. 105
Přehledné práce
Jeden názor na taktiku imunosupresivní léčby primární
chronické glumorulonefritidy
Karel Matoušovic ......................................................111
Doporučení
Odborné usmernenie Ministerstva zdravotnictvi
Slovenskej republiky na liečbu porúch minerálového
a kostného metabolizmu u pacientov
s chronickým ochorením obličiek .......................................121
Doporučení Èeské nefrologické společnosti
a Èeské společnosti klinické biochemie ÈLS JEP
k vyšetřování glomerulární filtrace
Romana Ryšavá, Tomáš Zima .............................................129
CONTENTS
Editorial ............................................................. 89
Contents .............................................................. 91
Abstracts
33rd Congress of The Slovak Society of Nephrology
with international participation .......................................95
Yellow pages
Original papers
Bicarbonate haemodialysis with a-concentrate
with citric acid (Citrasate®)
František Lopot, František Švára, Vladimír Polakovič ................. 105
Reviews
One opinion about immunosupressive therapy
of chronic primary glomerulonephritis
Karel Matoušovic ......................................................111
Recommendations
Guidelines of the Ministry of Health of the Slovak Republic
for the treatment of bone and mineral metabolism
disorders in patients with chronic kidney disease .................... 121
Recommendation of the Czech Society of Nephrology
and the Czech Society of Clinical Biochemistry CMA JEP
for investigation of glomerular filtration rate
Romana Ryšavá, Tomáš Zima .............................................129
